Complete enrollment in the sunRIZE Phase 3 study
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 4 Feb 2025
- Due
- 30 Jun 2025
- Delivered
- 28 May 2025
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“sunRIZE enrollment completion expected in Q2 2025”
What we found
Evidence strength B What the grades mean
Rezolute announced completion of sunRIZE Phase 3 enrollment on May 28, 2025, exceeding target with 62 participants, before the Q2 2025 deadline.
-
B Rezolute Announces Completion of Enrollment in the Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism Official press release confirming enrollment completion with 62 participants
-
C Rezolute Reports Third Quarter Fiscal 2025 Financial Results and Provides Business Update Prior update stating enrollment on track to complete in May 2025
-
D Rezolute Announces Completion of Enrollment in the Phase 3 sunRIZE Study Company investor relations page confirming same announcement
Checked 12 Sep 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical milestone
- Indicative materiality
- Medium rules
- Action
- Complete
- Language
- Expected (“expects”, “plans”)
How this entry was checked
- Commitment recordedRecorded from the company's filing.
- First checkAn AI model read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Gemini (Google), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Rezolute, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2025-RZLT-000161 · Corrections policy